{
    "id": 18270,
    "fullName": "AURKB G160V",
    "impact": "missense",
    "proteinEffect": "no effect - predicted",
    "geneVariantDescriptions": [
        {
            "description": "AURKB G160V lies within the active site of the Aurkb protein (PMID: 18559266). G160V has been demonstrated to have kinase activity similar to wild-type Aurkb protein in an in vitro assay, but is associated with resistance to Aurora Kinase inhibitors (PMID: 18559266).",
            "references": [
                {
                    "id": 4625,
                    "pubMedId": 18559266,
                    "title": "Molecular basis of drug resistance in aurora kinases.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18559266"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 9212,
        "geneSymbol": "AURKB",
        "terms": [
            "AURKB",
            "AIK2",
            "AIM-1",
            "AIM1",
            "ARK-2",
            "ARK2",
            "AurB",
            "aurkb-sv1",
            "aurkb-sv2",
            "IPL1",
            "PPP1R48",
            "STK-1",
            "STK12",
            "STK5"
        ]
    },
    "variant": "G160V",
    "createDate": "02/18/2016",
    "updateDate": "05/25/2018",
    "referenceTranscriptCoordinates": {
        "id": 112648,
        "transcript": "NM_004217",
        "gDna": "chr17:g.8206808C>A",
        "cDna": "c.479G>T",
        "protein": "p.G160V",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4609,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, colorectal cancer cells expressing AURKB G160V demonstrated resistance to ZM447439 in culture (PMID: 18559266).",
            "molecularProfile": {
                "id": 18608,
                "profileName": "AURKB G160V"
            },
            "therapy": {
                "id": 3523,
                "therapyName": "ZM447439",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4625,
                    "pubMedId": 18559266,
                    "title": "Molecular basis of drug resistance in aurora kinases.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18559266"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4614,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, colorectal cancer cells expressing AURKB G160V demonstrated resistance to MLN8054 in culture (PMID: 18559266).",
            "molecularProfile": {
                "id": 18608,
                "profileName": "AURKB G160V"
            },
            "therapy": {
                "id": 2333,
                "therapyName": "MLN8054",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4625,
                    "pubMedId": 18559266,
                    "title": "Molecular basis of drug resistance in aurora kinases.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18559266"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4613,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, colorectal cancer cells expressing AURKB G160V demonstrated resistance to Tozasertib (VX-680) in culture (PMID: 18559266).",
            "molecularProfile": {
                "id": 18608,
                "profileName": "AURKB G160V"
            },
            "therapy": {
                "id": 943,
                "therapyName": "Tozasertib",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4625,
                    "pubMedId": 18559266,
                    "title": "Molecular basis of drug resistance in aurora kinases.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18559266"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 18608,
            "profileName": "AURKB G160V",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 112647,
            "transcript": "NM_001313950",
            "gDna": "chr17:g.8206808C>A",
            "cDna": "c.479G>T",
            "protein": "p.G160V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112648,
            "transcript": "NM_004217",
            "gDna": "chr17:g.8206808C>A",
            "cDna": "c.479G>T",
            "protein": "p.G160V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}